Cost-effectiveness analysis of guidelines for antihypertensive care in Finland
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness analysis of guidelines for antihypertensive care in Finland ; volume:7 ; number:1 ; day:24 ; month:10 ; year:2007 ; pages:1-14 ; date:12.2007
BMC health services research ; 7, Heft 1 (24.10.2007), 1-14, 12.2007
- Urheber
-
Booth, Neill
- Beteiligte Personen und Organisationen
-
Jula, Antti
Aronen, Pasi
Kaila, Minna
Klaukka, Timo
Kukkonen-Harjula, Katriina
Reunanen, Antti
Rissanen, Pekka
Sintonen, Harri
Mäkelä, Marjukka
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-7-172
- URN
-
urn:nbn:de:1111-2016072121989
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Booth, Neill
- Jula, Antti
- Aronen, Pasi
- Kaila, Minna
- Klaukka, Timo
- Kukkonen-Harjula, Katriina
- Reunanen, Antti
- Rissanen, Pekka
- Sintonen, Harri
- Mäkelä, Marjukka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates